\begin{table}
\centering
\caption{Cancer Drug Response models}
\label{tab:Cancer_Drug_Response}
\begin{tabular}{|p{180pt}||p{40pt}|p{25pt}|p{25pt}|p{40pt}|p{25pt}|p{25pt}|}
\toprule
 name & PMID &N &NS & avgK &SDC & AFNS \\
\midrule
Bortezomib Responses in U266 Human Myeloma Cells & 26163548 & 67 & 1 & 1.8955 & 0.9147 & 0.2231 \\
BT474 Breast Cell Line Long-term ErbB Network & 24970389 & 24 & 5 & 3.0417 & 0.9439 & 0.3230 \\
BT474 Breast Cell Line Short-term ErbB Network & 24970389 & 16 & 5 & 3.1875 & 0.7614 & 0.1873 \\
HCC1954 Breast Cell Line Long-term ErbB Network & 24970389 & 23 & 4 & 3.1304 & 0.9643 & 0.4022 \\
HCC1954 Breast Cell Line Short-term ErbB Network & 24970389 & 16 & 5 & 3.1875 & 0.7841 & 0.1934 \\
SKBR3 Breast Cell Line Long-term ErbB Network & 24970389 & 25 & 4 & 3.4000 & 0.9458 & 0.2841 \\
SKBR3 Breast Cell Line Short-term ErbB Network & 24970389 & 16 & 5 & 2.8750 & 0.7908 & 0.3197 \\
Treatment of Castration-Resistant Prostate Cancer & 28361666 & 42 &14 & 1.5476 & 0.9964 & 0.0000 \\
\bottomrule
\end{tabular}
\end{table}
